Understanding Naturalistic Facial Expressions with Deep Learning and Multimodal Large Language Models

TPRO-NET: an EEG-based emotion recognition method reflecting subtle changes in emotion

Emotion recognition based on Electroencephalogram (EEG) has been applied in various fields, including human-computer interaction and healthcare. However, for the popular Valence-Arousal-Dominance emotion model, researchers often classify the dimensions into high and low categories, which cannot reflect subtle changes in emotion. Furthermore, there are issues with the design of EEG features and the efficiency of transformer. To address these issues, we have designed TPRO-NET, a neural network that takes differential entropy and enhanced differential entropy features as input and outputs emotion categories through convolutional layers and improved transformer encoders. For our experiments, we categorized the emotions in the DEAP dataset into 8 classes and those in the DREAMER dataset into 5 classes. On the DEAP and the DREAMER datasets, TPRO-NET achieved average accuracy rates of 97.63%/97.47%/97.88% and 98.18%/98.37%/98.40%, respectively, on the Valence/Arousal/Dominance dimension for the subject-dependent experiments. Compared to other advanced methods, TPRO-NET demonstrates superior performance.

Portable Facial Expression System Based on EMG Sensors and Machine Learning Models

One of the biggest challenges of computers is collecting data from human behavior, such as interpreting human emotions. Traditionally, this process is carried out by computer vision or multichannel electroencephalograms. However, they comprise heavy computational resources, far from final users or where the dataset was made. On the other side, sensors can capture muscle reactions and respond on the spot, preserving information locally without using robust computers. Therefore, the research subject is the recognition of the six primary human emotions using electromyography sensors in a portable device. They are placed on specific facial muscles to detect happiness, anger, surprise, fear, sadness, and disgust. The experimental results showed that when working with the CortexM0 microcontroller, enough computational capabilities were achieved to store a deep learning model with a classification store of 92%. Furthermore, we demonstrate the necessity of collecting data from natural environments and how they need to be processed by a machine learning pipeline.

Expanding the Horizons of Machine Learning in Nanomaterials to Chiral Nanostructures

Machine learning holds significant research potential in the field of nanotechnology, enabling nanomaterial structure and property predictions, facilitating materials design and discovery, and reducing the need for time-consuming and labor-intensive experiments and simulations. In contrast to their achiral counterparts, the application of machine learning for chiral nanomaterials is still in its infancy, with a limited number of publications to date. This is despite the great potential of machine learning to advance the development of new sustainable chiral materials with high values of optical activity, circularly polarized luminescence, and enantioselectivity, as well as for the analysis of structural chirality by electron microscopy. In this review, an analysis of machine learning methods used for studying achiral nanomaterials is provided, subsequently offering guidance on adapting and extending this work to chiral nanomaterials. An overview of chiral nanomaterials within the framework of synthesis-structure-property-application relationships is presented and insights on how to leverage machine learning for the study of these highly complex relationships are provided. Some key recent publications are reviewed and discussed on the application of machine learning for chiral nanomaterials. Finally, the review captures the key achievements, ongoing challenges, and the prospective outlook for this very important research field.

Artificial Intelligence-Based Management of Adult Chronic Myeloid Leukemia: Where Are We and Where Are We Going?

Artificial intelligence (AI) is emerging as a discipline capable of providing significant added value in Medicine, in particular in radiomic, imaging analysis, big dataset analysis, and also for generating virtual cohort of patients. However, in coping with chronic myeloid leukemia (CML), considered an easily managed malignancy after the introduction of TKIs which strongly improved the life expectancy of patients, AI is still in its infancy. Noteworthy, the findings of initial trials are intriguing and encouraging, both in terms of performance and adaptability to different contexts in which AI can be applied. Indeed, the improvement of diagnosis and prognosis by leveraging biochemical, biomolecular, imaging, and clinical data can be crucial for the implementation of the personalized medicine paradigm or the streamlining of procedures and services. In this review, we present the state of the art of AI applications in the field of CML, describing the techniques and objectives, and with a general focus that goes beyond Machine Learning (ML), but instead embraces the wider AI field. The present scooping review spans on publications reported in Pubmed from 2003 to 2023, and resulting by searching "chronic myeloid leukemia" and "artificial intelligence". The time frame reflects the real literature production and was not restricted. We also take the opportunity for discussing the main pitfalls and key points to which AI must respond, especially considering the critical role of the 'human' factor, which remains key in this domain.